Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
1.
Development ; 134(21): 3941-52, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17933795

ABSTRACT

Mammalian metaphase II (mII) exit and embryogenesis are induced at fertilisation by a signal thought to come from the sperm protein, phospholipase C-zeta (PLCZ1). Meiotic progression can also be triggered without sperm, as in parthenogenesis, although the classic mouse in vivo parthenogenetic model, LT/Sv, fails in meiosis I owing to an unknown molecular etiology. Here, we dissect PLCZ1 specificity and function in vivo and address its ability to interfere with maternal meiotic exit. Wild-type mouse Plcz1 expression was restricted to post-pubertal testes and the brains of both sexes, with region-specifying elements mapping to a 4.1 kb Plcz1 promoter fragment. When broad ectopic PLCZ1 expression was forced in independent transgenic lines, they initially appeared healthy. Their oocytes underwent unperturbed meiotic maturation to mII but subsequently exhibited autonomous intracellular free calcium oscillations, second polar body extrusion, pronucleus formation and parthenogenetic development. Transfer of transgenic cumulus cell nuclei into wild-type oocytes induced activation and development, demonstrating a direct effect of PLCZ1 analogous to fertilisation. Whereas Plcz1 transgenic males remained largely asymptomatic, females developed abdominal swellings caused by benign ovarian teratomas that were under-represented for paternally- and placentally-expressed transcripts. Plcz1 was not overexpressed in the ovaries of LT/Sv or in human germline ovarian tumours. The narrow spectrum of PLCZ1 activity indicates that it is modulated by tissue-restricted accessory factors. This work characterises a novel model in which parthenogenesis and tumourigenesis follow full meiotic maturation and are linked to fertilisation by PLCZ1.


Subject(s)
Ovarian Neoplasms/metabolism , Ovarian Neoplasms/pathology , Parthenogenesis , Phosphoinositide Phospholipase C/metabolism , Spermatozoa/metabolism , Animals , Base Sequence , Cell Transformation, Neoplastic , Cells, Cultured , Female , Gene Expression Regulation , Histone-Lysine N-Methyltransferase , Humans , Male , Meiosis , Mice , Mice, Transgenic , Molecular Sequence Data , Myeloid-Lymphoid Leukemia Protein/metabolism , Oocytes/cytology , Oocytes/metabolism , Ovarian Neoplasms/genetics , Phosphoinositide Phospholipase C/chemistry , Phosphoinositide Phospholipase C/genetics , Sensitivity and Specificity
2.
J Biochem ; 140(1): 95-103, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16798775

ABSTRACT

Werner syndrome is a genetic disorder characterized by premature aging and cancer-prone symptoms, and is caused by mutation of the WRN gene. WRN is a member of the RecQ helicase family and is thought to function in processes implicated in DNA replication and repair to maintain genome stability; however, its precise function is still unclear. We found that replication fork arrest markedly enhances chromatin binding of focus-forming activity 1 (FFA-1), a Xenopus WRN homolog, in Xenopus egg extracts. In addition to FFA-1, DNA polymerase delta (Poldelta) and replication protein A, but not DNA polymerase epsilon and proliferating cell nuclear antigen, accumulated increasingly on replication-arrested chromatin. Elevated accumulation of these proteins was dependent on formation of pre-replicative complexes (pre-RCs). Double-strand break (DSB) formation also enhanced chromatin binding of FFA-1, but not Poldelta, independently of pre-RC formation. In contrast to FFA-1, chromatin binding of Xenopus Bloom syndrome helicase (xBLM) only slightly increased after replication arrest or DSB formation. Thus, WRN-specific, distinct processes can be reproduced in the in vitro system in egg extracts, and this system is useful for biochemical analysis of WRN functions during DNA metabolism.


Subject(s)
Chromatin/metabolism , DNA Polymerase III/metabolism , DNA Replication/drug effects , DNA-Binding Proteins/metabolism , Xenopus Proteins/metabolism , Adenosine Triphosphatases/metabolism , Animals , Aphidicolin/pharmacology , Cell Cycle Proteins/pharmacology , Chromatin/drug effects , DNA Damage , DNA Helicases/metabolism , DNA Polymerase II/metabolism , Deoxycytosine Nucleotides/pharmacology , Female , Geminin , Male , Oocytes/drug effects , Oocytes/metabolism , Proliferating Cell Nuclear Antigen/metabolism , RecQ Helicases , Replication Protein A/metabolism , Spermatozoa/metabolism , Werner Syndrome Helicase , Xenopus
3.
EMBO J ; 25(4): 834-45, 2006 Feb 22.
Article in English | MEDLINE | ID: mdl-16456547

ABSTRACT

Fertilizable mammalian oocytes are arrested at the second meiotic metaphase (mII) by the cyclinB-Cdc2 heterodimer, maturation promoting factor (MPF). MPF is stabilized via the activity of an unidentified cytostatic factor (CSF), thereby suspending meiotic progression until fertilization. We here present evidence that a conserved 71 kDa mammalian orthologue of Xenopus XErp1/Emi2, which we term endogenous meiotic inhibitor 2 (Emi2) is an essential CSF component. Depletion in situ of Emi2 by RNA interference elicited precocious meiotic exit in maturing mouse oocytes. Reduction of Emi2 released mature mII oocytes from cytostatic arrest, frequently inducing cytodegeneration. Mos levels autonomously declined to undetectable levels in mII oocytes. Recombinant Emi2 reduced the propensity of mII oocytes to exit meiosis in response to activating stimuli. Emi2 and Cdc20 proteins mutually interact and Cdc20 ablation negated the ability of Emi2 removal to induce metaphase release. Consistent with this, Cdc20 removal prevented parthenogenetic or sperm-induced meiotic exit. These studies show in intact oocytes that the interaction of Emi2 with Cdc20 links activating stimuli to meiotic resumption at fertilization and during parthenogenesis in mammals.


Subject(s)
Cell Cycle Proteins/metabolism , F-Box Proteins/metabolism , Meiosis/physiology , Metaphase/physiology , Oocytes/physiology , Signal Transduction/physiology , Animals , Cdc20 Proteins , Cells, Cultured , Cyclin B/metabolism , F-Box Proteins/genetics , Female , Fertilization/physiology , Meiosis/drug effects , Mesothelin , Metaphase/drug effects , Mice , Oocytes/cytology , Parthenogenesis/drug effects , Parthenogenesis/physiology , RNA, Small Interfering/genetics , RNA, Small Interfering/pharmacology , Signal Transduction/drug effects
4.
Dev Biol ; 274(2): 370-83, 2004 Oct 15.
Article in English | MEDLINE | ID: mdl-15385165

ABSTRACT

Mammalian sperm-borne oocyte activating factor (SOAF) induces oocyte activation from a compartment that engages the oocyte cytoplasm, but it is not known how. A SOAF-containing extract (SE) was solubilized from the submembrane perinuclear matrix, a domain that enters the egg. SE initiated activation sufficient for full development. Microinjection coupled to tandem mass spectrometry enabled functional correlation profiling of fractionated SE without a priori assumptions about its chemical nature. Phospholipase C-zeta (PLCzeta) correlated absolutely with activating ability. Immunoblotting confirmed this and showed that the perinuclear matrix is the major site of 72-kDa PLCzeta. Oocyte activation was efficiently induced by 1.25 fg of sperm PLCzeta, corresponding to a fraction of one sperm equivalent (approximately 0.03). Immunofluorescence microscopy localized sperm head PLCzeta to a post-acrosomal region that becomes rapidly exposed to the ooplasm following gamete fusion. This multifaceted approach suggests a mechanism by which PLCzeta originates from an oocyte-penetrating assembly--the sperm perinuclear matrix--to induce mammalian oocyte activation at fertilization.


Subject(s)
Oocytes/physiology , Sperm-Ovum Interactions , Spermatozoa/enzymology , Type C Phospholipases/metabolism , Animals , Cell Fractionation , Female , Fertilization/physiology , Humans , Male , Mice , Microinjections , Molecular Sequence Data , Nuclear Matrix/chemistry , Nuclear Matrix/enzymology , Oocytes/cytology , Phosphoinositide Phospholipase C , Spermatozoa/chemistry , Spermatozoa/cytology , Swine , Type C Phospholipases/chemistry , Type C Phospholipases/genetics
5.
Genes Cells ; 9(3): 179-91, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15005706

ABSTRACT

DNA polymerases delta and epsilon (Poldelta and Polepsilon) are widely thought to be the major DNA polymerases that function in elongation during DNA replication in eukaryotic cells. However, the precise roles of these polymerases are still unclear. Here we comparatively analysed DNA replication in Xenopus egg extracts in which Poldelta or Polepsilon was immunodepleted. Depletion of either polymerase resulted in a significant decrease in DNA synthesis and accumulation of short nascent DNA products, indicating an elongation defect. Moreover, Poldelta depletion caused a more severe defect in elongation, as shown by sustained accumulation of both short nascent DNA products and single-stranded DNA gaps, and also by elevated chromatin binding of replication proteins that function more frequently during lagging strand synthesis. Therefore, our data strongly suggest the possibilities that Poldelta is essential for lagging strand synthesis and that this function of Poldelta cannot be substituted for by Polepsilon.


Subject(s)
DNA Polymerase III/physiology , DNA Polymerase II/physiology , DNA Replication , Xenopus/genetics , Animals , Antibodies/pharmacology , Cell Extracts/analysis , Chromatin/metabolism , DNA/metabolism , DNA Replication/drug effects , DNA-Binding Proteins/metabolism , Flap Endonucleases/metabolism , Ovum/chemistry , Ovum/enzymology , Proliferating Cell Nuclear Antigen/metabolism , Protein Binding , Replication Protein A , Replication Protein C , Xenopus/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL